Dr. Addy Squarer, MD

Dr. Squarer practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Squarer's NPI, 1679581425, was assigned on August 4, 2006. Dr. Squarer graduated from UC Davis School of Medicine in 1990. Dr. Squarer holds California license G73060.

Dr. Squarer's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Squarer's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Squarer is also affiliated with Santa Clara Valley Medical Center. The medical group on file is El Camino Health Medical Network. Dmand AI also links Dr. Squarer to 3 more hospitals, 2 dialysis centers, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Squarer practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Squarer's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Squarer is board certified in nephrology by the American Board of Internal Medicine. Dr. Squarer is licensed in California.

Dmand AI lists chronic anemia, chronic kidney disease and parathyroid gland disorder among the conditions Dr. Squarer treats.

CMS data shows 2,110 Medicare services from Dr. Squarer across 16 procedure codes in 2024, for 370 Medicare patients. Medicare paid $167,628 for them.

CMS counts 370 Medicare patients who saw Dr. Squarer in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Squarer's median patient age at 76, with 60% women.

In 2024, Dr. Squarer wrote 4,576 Medicare Part D claims for 305 patients. 81% of them were for generic drugs. CMS names the drug for 3,968 of them, across 99 drugs with 11 or more claims each, at $609,443 in total drug cost. In 2023, CMS named 3,764 claims across 88 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Squarer for performance year 2024, reported individually. Dr. Squarer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Squarer as offering telehealth.

Dmand AI links 2 papers to Dr. Squarer. The most frequent topics are Glomerular Filtration Rate and Kidney Glomerulus. Dr. Squarer's most frequent co-authors are Kevin V. Lemley, MD, Richard Alan Lafayette, MD and Massy Safai, MD.

CMS Open Payments shows 293 general payments to Dr. Squarer from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $1,357.

Dr. Squarer graduated from UC Davis School of Medicine in 1990.

Dr. Squarer is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.